Zgjim Osmani
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Clinical implications of imlifidase interference in antibody screening and transfusion management.
Journal: Transfusion
Published: June 30, 2025
Metabolic dysfunction-associated steatohepatitis reduces interferon and macrophage liver gene signatures in patients with chronic hepatitis B.
Journal: Journal of hepatology
Published: September 05, 2024
Intrahepatic plasma cells, but not atypical memory B cells, associate with clinical phases of chronic hepatitis B.
Journal: European journal of immunology
Published: February 19, 2024
B-Cell Activation Gene Signature in Blood and Liver of Hepatitis B e Antigen-Positive Patients With Immune Active Chronic Hepatitis B.
Journal: The Journal of infectious diseases
Published: February 19, 2024
Disruption of memory B-cell trafficking by belimumab in patients with systemic lupus erythematosus.
Journal: Rheumatology (Oxford, England)
Published: December 01, 2023
Association of HBsAg levels with differential gene expression in NK, CD8 T, and memory B cells in treated patients with chronic HBV.
Journal: JHEP reports : innovation in hepatology
Published: October 07, 2023
Recent Insights into the Role of B Cells in Chronic Hepatitis B and C Infections.
Journal: Pathogens (Basel, Switzerland)
Published: May 12, 2023
Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients.
Journal: Hepatology (Baltimore, Md.)
Published: August 19, 2022
Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence.
Journal: Lupus science & medicine
Published: January 14, 2021
Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia.
Journal: British journal of haematology
Published: August 12, 2020
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE.
Journal: Rheumatology (Oxford, England)
Published: July 29, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026